We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Traeger
COOK
$164M
| $312K | ﹤0.01% |
5,122
+2,772
| +118% | +$212K |
|
|
CSW
877
CSW Industrials
CSW
$4.87B
| $310K | ﹤0.01% |
1,277
-1,493
| -54% | -$401K |
|
878
BioLife Solutions
BLFS
$1.56B
| $309K | ﹤0.01% |
12,131
-263
| -2% | -$6.24K |
|
879
Cartesian Therapeutics
RNAC
$225M
| $307K | ﹤0.01% |
30,001
-11,316
| -27% | -$127K |
|
880
Old Second Bancorp
OSBC
$1.3B
| $301K | ﹤0.01% |
17,409
+2,309
| +15% | +$41.6K |
|
881
Orange County Bancorp
OBT
$521M
| $299K | ﹤0.01% |
11,880
| – | – |
|
882
Methode Electronics
MEI
$525M
| $298K | ﹤0.01% |
+39,497
| New | +$294K |
|
883
Zevia
ZVIA
$116M
| $298K | ﹤0.01% |
109,421
-330,501
| -75% | -$952K |
|
884
Caleres
CAL
$447M
| $294K | ﹤0.01% |
22,535
| – | – |
|
885
Metallus
MTUS
$879M
| $288K | ﹤0.01% |
17,434
| – | – |
|
886
PACCAR
PCAR
$72.7B
| $282K | ﹤0.01% |
2,871
-421,957
| -99% | -$41.6M |
|
887
Merck
MRK
$326B
| $281K | ﹤0.01% |
3,346
-48,795
| -94% | -$4.02M |
|
|
BHR
888
Braemar Hotels & Resorts
BHR
$160M
| $277K | ﹤0.01% |
+101,626
| New | +$257K |
|
|
MRC
889
DELISTED
MRC Global
MRC
| $274K | ﹤0.01% |
19,029
| – | – |
|
890
OP Bancorp
OPBK
$241M
| $274K | ﹤0.01% |
19,687
+1,160
| +6% | +$16K |
|
|
BFS
891
Saul Centers
BFS
$870M
| $263K | ﹤0.01% |
8,241
-10,377
| -56% | -$343K |
|
892
ProPetro Holding
PUMP
$1.31B
| $259K | ﹤0.01% |
49,414
-150,045
| -75% | -$796K |
|
893
Mesa Laboratories
MLAB
$559M
| $258K | ﹤0.01% |
+3,857
| New | +$278K |
|
894
Forrester Research
FORR
$200M
| $258K | ﹤0.01% |
24,314
-1,558
| -6% | -$15.8K |
|
895
Nautilus Biotechnolgy
NAUT
$152M
| $254K | ﹤0.01% |
301,012
+46,153
| +18% | +$33.9K |
|
|
FSUN
896
FirstSun Capital Bancorp
FSUN
$1.84B
| $253K | ﹤0.01% |
6,523
-4,752
| -42% | -$179K |
|
897
Capitol Federal Financial
CFFN
$1.09B
| $252K | ﹤0.01% |
39,684
-33,636
| -46% | -$210K |
|
898
Guidewire Software
GWRE
$13.3B
| $250K | ﹤0.01% |
1,086
-13,587
| -93% | -$3.09M |
|
899
Seer Inc
SEER
$118M
| $244K | ﹤0.01% |
112,555
-214,852
| -66% | -$457K |
|
900
Kyndryl
KD
$2.94B
| $241K | ﹤0.01% |
8,022
-2,674
| -25% | -$91.8K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.